Complicated nosocomial pneumonia due to Legionella pneumophila in an immunocompromised child

Scand J Infect Dis. 2002;34(3):219-21. doi: 10.1080/00365540110077317.

Abstract

An immunocompromised child developed necrotizing pneumonia with BAL cultures growing Legionella pneumophila resistant to treatment, including erythromycin and rifampicin. Ciprofloxacin and clarithromycin reversed the clinical course; their use as first-line drugs is justifiable and a high index of suspicion for the occurrence of legionellosis is warranted.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Child, Preschool
  • Ciprofloxacin / therapeutic use
  • Clarithromycin / therapeutic use
  • Cross Infection / complications*
  • Cross Infection / drug therapy
  • Cross Infection / microbiology*
  • Drug Resistance, Multiple, Bacterial
  • Humans
  • Immunocompromised Host*
  • Legionella pneumophila / isolation & purification*
  • Legionnaires' Disease / complications*
  • Legionnaires' Disease / drug therapy
  • Legionnaires' Disease / microbiology
  • Male
  • Nutrition Disorders / complications
  • Pneumonia, Bacterial / complications*
  • Pneumonia, Bacterial / drug therapy
  • Pneumonia, Bacterial / microbiology*

Substances

  • Anti-Bacterial Agents
  • Ciprofloxacin
  • Clarithromycin